Who
Marc Schwabish
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Tectonic Therapeutic.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jun 2024
- Last trade
- 25 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 2 Oct 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code F | $9,728411 at $23.67 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,750 at $0.00 | filing |
| 3 Sep 2026filed 8 Sep 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,750 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code A | —19,500 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,750 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,750 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code A | —19,500 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $11K4,500 at $2.38 | filing |
| 10 Feb 2026filed 12 Feb 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,500 | filing |
| 10 Feb 2026filed 12 Feb 2026 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,500 | filing |
| 10 Feb 2026filed 12 Feb 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $11K4,500 at $2.38 | filing |
| 4 Feb 2026filed 10 Feb 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code F | $38K1,619 at $23.22 | filing |
| 4 Feb 2026filed 10 Feb 2026 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code F | $38K1,619 at $23.22 | filing |
| 25 Sep 2025filed 29 Sep 2025 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,650 at $0.00 | filing |
| 25 Sep 2025filed 29 Sep 2025 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code A | —4,210 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,496 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code A | —14,023 at $0.00 | filing |
| 28 Jan 2025filed 29 Jan 2025 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,700 | filing |
| 28 Jan 2025filed 29 Jan 2025 | TECX Tectonic TherapeuticBiotechnology | SEC FORM 4 Code M | $6,4262,700 at $2.38 | filing |
| 9 Dec 2024filed 11 Dec 2024 | TECX Tectonic Therapeuticoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.